Jorge Daza

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Bérengère Salomé, John P. Sfakianos, Daniel Ranti et al. · Cancer Cell · 2022 · 112 citations · Full text

Urology, Cancer Immunosurveillance, Genitourinary Cancer +6

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers

John P. Sfakianos, Jorge Daza, Yang Hu et al. · Nature Communications · 2020 · 66 citations · Full text

Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma

Alberto Martini, Jorge Daza, Elona Poltiyelova et al. · British Journal of Urology · 2019 · 43 citations

Survival of Patients with Muscle-Invasive Urothelial Cancer of the Bladder with Residual Disease at Time of Cystectomy: A Comparative Survival Analysis of Treatment Modalities in the National Cancer Database

John Pfail, François Audenet, Alberto Martini et al. · Bladder Cancer · 2020 · 17 citations

National Cancer Database, Residual Disease, Urology +14

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma

Alberto Martini, Ugo Giovanni Falagario, Nikhil Waingankar et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 14 citations

Urology, Genitourinary Cancer, Medicine +2